Therapeutic Misconception in Psychiatry Research: A Systematic Review
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Therapeutic misconception (TM) denotes the phenomenon in which research subjects conflate research purpose, protocols and procedures with clinical treatment. We examined the prevalence, contributory factors, clinical associations, impact, and collated solutions on TM within psychiatric research, and made suggestions going ahead. Literature search for relevant empirical research papers was conducted until February 2015. Eighty-eight reports were extracted, of which 31 were selected, summarised into different headings for discussion of implications and collated solutions of TM. We found variable and high rates of TM (ranging from 12.5% to 86%) in some psychiatry research populations. Contributory factors to TM included perceived medical roles of researchers, media, research setting and subject factors. Greater TM in affective, neurodevelopmental and psychotic spectrum conditions were associated with demographic variables (such as lower education, increased age), clinical factors (such as poor insight, cognitive deficits, increased symptoms, poorer self-rated quality of health), and social functioning (such as decreased independence). Inattention to TM may lead to frustration, negative impression and abandonment of participation in psychiatry research. Strategies such as the employment of a neutral educator during the informed consent process and education modules may be effective in addressing TM. Further research is warranted to examine the different TM facets, specific clinical correlates and more effective management strategies.
Abstract
Therapeutic misconception (TM) denotes the phenomenon in which research subjects conflate research purpose, protocols and procedures with clinical treatment. We examined the prevalence, contributory factors, clinical associations, impact, and collated solutions on TM within psychiatric research, and made suggestions going ahead. Literature search for relevant empirical research papers was conducted until February 2015. Eighty-eight reports were extracted, of which 31 were selected, summarised into different headings for discussion of implications and collated solutions of TM. We found variable and high rates of TM (ranging from 12.5% to 86%) in some psychiatry research populations. Contributory factors to TM included perceived medical roles of researchers, media, research setting and subject factors. Greater TM in affective, neurodevelopmental and psychotic spectrum conditions were associated with demographic variables (such as lower education, increased age), clinical factors (such as poor insight, cognitive deficits, increased symptoms, poorer self-rated quality of health), and social functioning (such as decreased independence). Inattention to TM may lead to frustration, negative impression and abandonment of participation in psychiatry research. Strategies such as the employment of a neutral educator during the informed consent process and education modules may be effective in addressing TM. Further research is warranted to examine the different TM facets, specific clinical correlates and more effective management strategies.
참고문헌 (75)
- Appelbaum PS, "Therapeutic misconception in research subjects: development and validation of a measure", Clin Trials, 9, pp.748~761 (2012)
- Appelbaum PS, "The therapeutic misconception:informed consent in psychiatric research", Int J Law Psychiatry, 5, pp.319~329 (1982)
- Appelbaum PS, "False hopes and best data: consent to research and the therapeutic misconception", Hastings Cent Rep, 17, pp.20~24 (1987)
- Henderson GE, "Clinical trials and medical care:defining the therapeutic misconception", PLoS Med, 4, pp.e324~ (2007)
- Henderson GE, "Therapeutic misconception in early phase gene transfer trials", Soc Sci Med, 62, pp.239~253 (2006)
- Goldberg DS, "Eschewing definitions of the therapeutic misconception:a family resemblance analysis", J Med Philos, 36, pp.296~320 (2011)
- Kim SY, "An approach to evaluating the therapeutic misconception", IRB, 31, pp.7~14 (2009)
- Miller FG, "Evaluating the therapeutic misconception", Kennedy Inst Ethics J, 16, pp.353~366 (2006)
- Appelbaum PS, "Therapeutic misconception in clinical research: frequency and risk factors", IRB, 26, pp.1~8 (2004)
- Appelbaum PS, "Twenty-five years of therapeutic misconception", Hastings Cent Rep, 38, pp.5~6 (2008)
- Dunn LB, "Assessment of therapeutic misconception in older schizophrenia patients with a brief instrument", Am J Psychiatry, 163, pp.500~506 (2006)
- Fisher CE, "The ethics of research on deep brain stimulation for depression: decisional capacity and therapeutic misconception", Ann N Y Acad Sci, 1265, pp.69~79 (2012)
- Horng S, "Misunderstanding in clinical research:distinguishing therapeutic misconception, therapeutic misestimation, and therapeutic optimism", IRB, 25, pp.11~16 (2003)
- Lidz CW, "Therapeutic misconception and the appreciation of risks in clinical trials", Soc Sci Med, 58, pp.1689~1697 (2004)
- Lidz CW, "The therapeutic misconception:problems and solutions", Med Care, 40(9 Suppl), pp.V55~V63 (2002)
- Vitiello B, "Research knowledge among parents of children participating in a randomized clinical trial", J Am Acad Child Adolesc Psychiatry, 44, pp.145~149 (2005)
- Wasan AD, "Reasons for participation in pain research: can they indicate a lack of informed consent?", Pain Med, 10, pp.111~119 (2009)
- Wazaify M, "Expression of therapeutic misconception amongst Egyptians: a qualitative pilot study", BMC Med Ethics, 10, pp.7~ (2009)
- Hoop JG, "Ethical issues in psychiatric research on children and adolescents", Child Adolesc Psychiatr Clin N Am, 17, pp.127~148 (2008)
- Dunn LB, "Understanding of placebo controls among older people with schizophrenia", Schizophr Bull, 32, pp.137~146 (2006)
- Fischer BA, "Participants with schizophrenia retain the information necessary for informed consent during clinical trials", J Clin Psychiatry, 74, pp.622~627 (2013)
- Joffe S, "Views of American oncologists about the purposes of clinical trials", J Natl Cancer Inst, 94, pp.1847~1853 (2002)
- Timmermans S, "Clinical trials as treatment option: bioethics and health care disparities in substance dependency", Soc Sci Med, 69, pp.1784~1790 (2009)
- Kodish E, "Communication of randomization in childhood leukemia trials", JAMA, 291, pp.470~475 (2004)
- Belkin GS, "Misconceived bioethics?: The misconception of the “therapeutic misconception”", Int J Law Psychiatry, 29, pp.75~85 (2006)
- Cassileth BR, "Attitudes toward clinical trials among patients and the public", JAMA, 248, pp.968~970 (1982)
- Daugherty C, "Perceptions of cancer patients and their physicians involved in phase I trials", J Clin Oncol, 13, pp.1062~1072 (1995)
- Gallo C, "Informed versus randomised consent to clinical trials", Lancet, 346, pp.1060~1064 (1995)
- Racine E, ""Currents of hope": neurostimulation techniques in U.S. and U.K. print media", Camb Q Healthc Ethics, 16, pp.312~316 (2007)
- Skuban T, "Informed consent in deep brain stimulation - ethical considerations in a stress field of pride and prejudice", Front Integr Neurosci, 5, pp.7~ (2011)
- Kasner SE, "Community views on neurologic emergency treatment trials", Ann Emerg Med, 57, pp.346~354 (2011)
- Appelbaum PS, "The Oxford textbook of clinical research ethics", pp.633~644 (2008), Oxford University Press
- Brody H, "The clinician-investigator: unavoidable but manageable tension", Kennedy Inst Ethics J, 13, pp.329~346 (2003)
- Ness DE, "Why does informed consent fail? A discourse analytic approach", J Am Acad Psychiatry Law, 37, pp.349~362 (2009)
- Miller FG, "The therapeutic orientation to clinical trials", N Engl J Med, 348, pp.1383~1386 (2003)
- Kimmelman J, "Therapeutic optimism in the consent forms of phase 1 gene transfer trials: an empirical analysis", J Med Ethics, 31, pp.209~214 (2005)
- Advisory committee on human radiation experiments: final report, "Faden RR", Joseph Henry Press, ~ (1995)
- Gotay CC, "Accrual to cancer clinical trials: directions from the research literature", Soc Sci Med, 33, pp.569~577 (1991)
- Schaeffer MH, "The impact of disease severity on the informed consent process in clinical research", Am J Med, 100, pp.261~268 (1996)
- Easter MM, "The many meanings of care in clinical research", Sociol Health Illn, 28, pp.695~712 (2006)
- Brody JL, "Family and physician influence on asthma research participation decisions for adolescents: the effects of adolescent gender and research risk", Pediatrics, 118, pp.e356~e362 (2006)
- de Melo-Martín I, "Beyond informed consent: the therapeutic misconception and trust", J Med Ethics, 34, pp.202~205 (2008)
- Angst DB, "Clinical trials for children: in whose best interest?", Bull Park Ridge Cent, (18), pp.9~10 (2000)
- Weinfurt KP, "Patient expectations of benefit from phase I clinical trials:linguistic considerations in diagnosing a therapeutic misconception", Theor Med Bioeth, 24, pp.329~344 (2003)
- Fisher CB, "Capacity of persons with mental retardation to consent to participate in randomized clinical trials", Am J Psychiatry, 163, pp.1813~1820 (2006)
- Miller FG, "The relevance of empirical research in bioethics", Schizophr Bull, 32, pp.37~41 (2006)
- Sobel D, "Sleep study leaves subject feeling angry and confused", The New York Times. Jul 17 Sect C, 3C~ (1980)
- Tracking the care of patients with severe chronic illness:The Dartmouth atlas of health care 2008, "Wennberg JE", The Dartmouth Institute for Health Policy and Clinical Practice, ~ (2008)
- Pace C, "Enrolling the uninsured in clinical trials: an ethical perspective", Crit Care Med, 31(3 Suppl), pp.S121~S125 (2003)
- Elkashef A, "The NIDA Methamphetamine Clinical Trials Group: a strategy to increase clinical trials research capacity", Addiction, 102(Suppl 1), pp.107~113 (2007)
- Epstein S, "Impure science: AIDS, activism, and the politicsof knowledge" (1996), University of California Press
- Glannon W, "Phase I oncology trials: why the therapeutic misconception will not go away", J Med Ethics, 32, pp.252~255 (2006)
- Swekoski D, "The gambler's fallacy, the therapeutic misconception, and unrealistic optimism", IRB, 35, pp.1~6 (2013)
- Kimmelman J, "The therapeutic misconception at 25: treatment, research, and confusion", Hastings Cent Rep, 37, pp.36~42 (2007)
- Shatz D, "Randomized clinical trials and the problem of suboptimal care: an overview of the controversy", Cancer Invest, 8, pp.191~205 (1990)
- Henderson GE, "Uncertain benefit: investigators'views and communications in early phase gene transfer trials", Mol Ther, 10, pp.225~231 (2004)
- Aaronson NK, "Telephone-based nursing intervention improves the effectiveness of the informed consent process in cancer clinical trials", J Clin Oncol, 14, pp.984~996 (1996)
- Benson PR, "Information disclosure, subject understanding, and informed consent in psychiatric research", Law Hum Behav, 12, pp.455~475 (1988)
- Simes RJ, "Randomised comparison of procedures for obtaining informed consent in clinical trials of treatment for cancer", Br Med J (Clin Res Ed), 293, pp.1065~1068 (1986)
- Annas GJ, "The Nazi doctors and the Nuremberg code: Human rights in human experimentation" (1992), Oxford University Press
- "Nova Production and WGBH Educational Foundation", 1993
- Hornblum AM, "Acres of skin: Human experiments at Holmesburg prison" (1998), Routledge
- Lifton RJ, "The Nazi doctors: Medical killing and the psychology of genocide" (2000), Basic Books
- Cunningham PJ, "Beyond parity: primary care physicians'perspectives on access to mental health care", Health Aff (Millwood), 28, pp.w490~w501 (2009)
- Miller M, "Phase I cancer trials. A collusion of misunderstanding", Hastings Cent Rep, 30, pp.34~43 (2000)
- Bankert EA, "Institutional review board: management and function" (2006), Jones and Bartlett Publishers
- Klitzman RL, "How IRBs view and make decisions about consent forms", J Empir Res Hum Res Ethics, 8, pp.8~19 (2013)
- "Ethics in clinical research: A history of human subject protections and practical implementation of ethical standards" (2004)[URL]
- Featherstone K, "Random allocation or allocation at random? Patients' perspectives of participation in a randomised controlled trial", BMJ, 317, pp.1177~1180 (1998)
- Waggoner WC, "Who understands? A survey of 25 words or phrases commonly used in proposed clinical research consent forms", IRB, 17, pp.6~9 (1995)
- Matutina RE, "The concept analysis of therapeutic misconception", Nurse Res, 17, pp.83~90 (2010)
- Shore D, "Ethical issues in schizophrenia research: a commentary on some current concerns", Schizophr Bull, 32, pp.26~29 (2006)
- Meurer WJ, "Adaptive clinical trials:a partial remedy for the therapeutic misconception?", JAMA, 307, pp.2377~2378 (2012)
- Dresser R, "The ubiquity and utility of the therapeutic misconception", Soc Philos Policy, 19, pp.271~294 (2002)
- Miller FG, "A critique of clinical equipoise. Therapeutic misconception in the ethics of clinical trials", Hastings Cent Rep, 33, pp.19~28 (2003)
